Artículos de revistas sobre el tema "Anthracyclines"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Anthracyclines".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Sorensen, K., G. Levitt, D. Sebag-Montefiore, C. Bull y I. Sullivan. "Cardiac function in Wilms' tumor survivors." Journal of Clinical Oncology 13, n.º 7 (julio de 1995): 1546–56. http://dx.doi.org/10.1200/jco.1995.13.7.1546.
Texto completoKrook, James Edward, Akhil Kumar, Marc L. Fishman, William S. Shimp, Laura Rose Bobolts, Val Fishman, Sharon Davis et al. "Community use of anthracyclines in metastatic breast cancer (MBC)." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): 1080. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1080.
Texto completoKumar, Akhil, Marc L. Fishman, William S. Shimp, Laura Rose Bobolts, James Edward Krook, Val Fishman, Sharon Davis et al. "Community use of anthracyclines for adjuvant HER2-positive breast cancer (BC)." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): e11609-e11609. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e11609.
Texto completoNeppelenbroek, Suzanne I. M., Yvonne M. Geurts, Berthe M. P. Aleman, Cecile P. M. Janus, Saskia E. Rademakers, Roel J. de Weijer, Richard W. M. Van Der Maazen et al. "Anthracycline exposure and breast cancer risk in female Hodgkin lymphoma survivors." Journal of Clinical Oncology 39, n.º 15_suppl (20 de mayo de 2021): 12074. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.12074.
Texto completoBlanco, Javier G., Can-Lan Sun, Wendy Landier, Lu Chen, Diego Esparza-Duran, Wendy Leisenring, Allison Mays et al. "Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group". Journal of Clinical Oncology 30, n.º 13 (1 de mayo de 2012): 1415–21. http://dx.doi.org/10.1200/jco.2011.34.8987.
Texto completoRybczyńska-Tkaczyk, Kamila. "Enhanced Efficiency of the Removal of Cytostatic Anthracycline Drugs Using Immobilized Mycelium of Bjerkandera adusta CCBAS 930". Molecules 26, n.º 22 (12 de noviembre de 2021): 6842. http://dx.doi.org/10.3390/molecules26226842.
Texto completoTorkkell, Sirke, Tero Kunnari, Kaisa Palmu, Juha Hakala, Pekka Mäntsälä y Kristiina Ylihonko. "Identification of a Cyclase Gene Dictating the C-9 Stereochemistry of Anthracyclines from Streptomyces nogalater". Antimicrobial Agents and Chemotherapy 44, n.º 2 (1 de febrero de 2000): 396–99. http://dx.doi.org/10.1128/aac.44.2.396-399.2000.
Texto completoKrell, J., C. Harper-Wynne, D. Miles, V. Misra, S. Cleator, D. Krell y C. Palmieri. "What is the evidence for rechallenging with anthracyclines or taxanes in metastatic breast cancer? A review of the data". Journal of Clinical Oncology 27, n.º 15_suppl (20 de mayo de 2009): 1072. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.1072.
Texto completoChen, Wei-Wu, Twan Ying Chang, Shu-Min Huang, Ching-Hung Lin, Chiun Hsu, Ann-Lii Cheng y Yen-Shen Lu. "The first two lines of chemotherapy for anthracycline-naïve metastatic breast cancer: A comparative study of efficacy between anthracyclines and nonanthracyclines." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): 1061. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1061.
Texto completoGianni, Luca, Larry Norton, Norman Wolmark, Thomas M. Suter, Gianni Bonadonna y Gabriel N. Hortobagyi. "Role of Anthracyclines in the Treatment of Early Breast Cancer". Journal of Clinical Oncology 27, n.º 28 (1 de octubre de 2009): 4798–808. http://dx.doi.org/10.1200/jco.2008.21.4791.
Texto completoSuarato, Antonino, Francesco Angelucci y Cristina Geroni. "Ring-B Modified Anthracyclines". Current Pharmaceutical Design 5, n.º 3 (marzo de 1999): 217–27. http://dx.doi.org/10.2174/1381612805666230109215627.
Texto completoDozic, Sanela, Erin J. Howden, James R. Bell, Kimberley M. Mellor, Lea M. D. Delbridge y Kate L. Weeks. "Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy". Cells 12, n.º 9 (4 de mayo de 2023): 1312. http://dx.doi.org/10.3390/cells12091312.
Texto completoGennari, A., M. Sormani, M. Costantini, P. Pronzato, R. Rosso y P. Bruzzi. "Anthracycline regimens versus CMF in the adjuvant treatment of early breast cancer (EBC): A matter of difference". Journal of Clinical Oncology 24, n.º 18_suppl (20 de junio de 2006): 569. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.569.
Texto completoEgas Bejar, Daniela E., Joy M. Fulbright, Fernando F. Corrales-Medina, Mary E. Irwin, Blake Johnson y Joya Chandra. "Uncovering Cardioprotective Strategies For Anthracycline Therapy By Analysis Of Redox and Apoptotic Effects". Blood 122, n.º 21 (15 de noviembre de 2013): 1293. http://dx.doi.org/10.1182/blood.v122.21.1293.1293.
Texto completoBehrouzian, Mahsa, Babak Najibi, Sabahat Haghi, Chehreh Mahdavi, Kaveh Jaseb y Ehsan Ghaedi. "Prevalence of Major Cardiac Events of Anthracycline-Induced Cardiotoxicity in Southwestern Iran: Different Response Patterns to Cumulative Dose". Current Drug Therapy 15, n.º 1 (14 de enero de 2020): 78–84. http://dx.doi.org/10.2174/1574885514666190311145607.
Texto completoKhan, Meraj A., Adam D’Ovidio, Harvard Tran y Nades Palaniyar. "Anthracyclines Suppress Both NADPH Oxidase- Dependent and -Independent NETosis in Human Neutrophils". Cancers 11, n.º 9 (7 de septiembre de 2019): 1328. http://dx.doi.org/10.3390/cancers11091328.
Texto completode Vries, Elisabeth G. E. y Jan G. Zijlstra. "Morpholinyl anthracyclines: Option for reversal of anthracycline resistance". European Journal of Cancer and Clinical Oncology 26, n.º 6 (enero de 1990): 659–60. http://dx.doi.org/10.1016/0277-5379(90)90110-f.
Texto completoMarinello, Jessica, Maria Delcuratolo y Giovanni Capranico. "Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives". International Journal of Molecular Sciences 19, n.º 11 (6 de noviembre de 2018): 3480. http://dx.doi.org/10.3390/ijms19113480.
Texto completoMontaigne, David, Christopher Hurt y Remi Neviere. "Mitochondria Death/Survival Signaling Pathways in Cardiotoxicity Induced by Anthracyclines and Anticancer-Targeted Therapies". Biochemistry Research International 2012 (2012): 1–12. http://dx.doi.org/10.1155/2012/951539.
Texto completoQiao, Xiaohang, Sabina Y. van der Zanden, Dennis P. A. Wander, Daniel M. Borràs, Ji-Ying Song, Xiaoyang Li, Suzanne van Duikeren et al. "Uncoupling DNA damage from chromatin damage to detoxify doxorubicin". Proceedings of the National Academy of Sciences 117, n.º 26 (17 de junio de 2020): 15182–92. http://dx.doi.org/10.1073/pnas.1922072117.
Texto completoHerzig, R. H., H. M. Lazarus, S. N. Wolff, G. L. Phillips y G. P. Herzig. "High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia." Journal of Clinical Oncology 3, n.º 7 (julio de 1985): 992–97. http://dx.doi.org/10.1200/jco.1985.3.7.992.
Texto completoLevina, V. D., M. G. Poltavskaya, V. P. Sedov, P. Sh Chomakhidze, L. V. Bolotina, T. I. Deshkina, M. D. Kuklina et al. "The role of left ventricle global longitudinal srain in prediction of chemotherapy — induced cardiotoxicity in breast cancer patients treated by low and moderate cumulative doses of anthracyclines". Medical alphabet, n.º 33 (12 de enero de 2023): 19–26. http://dx.doi.org/10.33667/2078-5631-2022-33-19-26.
Texto completoAl-Batran, S., M. Scholz y E. Jäger. "Anthracycline-rechallenge using pegylated liposomal doxorubicin (PLD) in previously treated patients with metastatic breast cancer (MBC): A meta-analysis using pooled individual data from four prospective trials". Journal of Clinical Oncology 27, n.º 15_suppl (20 de mayo de 2009): 1047. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.1047.
Texto completoMenna, Pierantonio y Emanuela Salvatorelli. "Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview". Chemotherapy 62, n.º 3 (2017): 159–68. http://dx.doi.org/10.1159/000455823.
Texto completoVeiga, Lene H. S., Rochelle E. Curtis, Lindsay M. Morton, Diana Withrow, Rebecca M. Howell, Susan A. Smith, Rita Weathers et al. "Combined effect of radiotherapy and anthracyclines on risk of breast cancer among female childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS)." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): 10053. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.10053.
Texto completoAplenc, R., J. Blanco, W. Leisenring, S. Davies, M. Relling, L. Robison, C. Sklar, M. Stovall y S. Bhatia. "Polymorphisms in candidate genes in patients with congestive heart failure (CHF) after childhood cancer: A Report from the Childhood Cancer Survivor Study (CCSS)". Journal of Clinical Oncology 24, n.º 18_suppl (20 de junio de 2006): 9004. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.9004.
Texto completoArmenian, Saro y Smita Bhatia. "Predicting and Preventing Anthracycline-Related Cardiotoxicity". American Society of Clinical Oncology Educational Book, n.º 38 (mayo de 2018): 3–12. http://dx.doi.org/10.1200/edbk_100015.
Texto completoMata, Danilo Giffoni M. M., Matthew Castelo, Rinku Sutradhar, Lena Nguyen, Neil Faught, Danielle Rodin, Ezra Hahn et al. "Abstract P4-06-10: Is Anthracycline Chemotherapy Essential in the Treatment of Women with Breast Cancer? – A Real World Comparison in the Neoadjuvant Setting". Cancer Research 83, n.º 5_Supplement (1 de marzo de 2023): P4–06–10—P4–06–10. http://dx.doi.org/10.1158/1538-7445.sabcs22-p4-06-10.
Texto completoHamilton, Joseph Z., Kerry Klussman, Rebecca Mahzereh, Jessica Simmons, Michelle Ulrich, Shyra J. Gardai, Peter D. Senter y Patrick J. Burke. "Abstract 2013: Oxidized anthracycline payloads induce anti-tumor immunogenic cell-death and show linker-dependent tolerability when delivered as ADCs". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 2013. http://dx.doi.org/10.1158/1538-7445.am2023-2013.
Texto completoKremer, L. C. M., E. C. van Dalen, M. Offringa, J. Ottenkamp y P. A. Voûte. "Anthracycline-Induced Clinical Heart Failure in a Cohort of 607 Children: Long-Term Follow-Up Study". Journal of Clinical Oncology 19, n.º 1 (1 de enero de 2001): 191–96. http://dx.doi.org/10.1200/jco.2001.19.1.191.
Texto completoFulbright, Joy Marie y Joya Chandra. "“Limiting Anthracycline-Induced Cardiotoxicity Using Amrubicin in Leukemia Systems”." Blood 114, n.º 22 (20 de noviembre de 2009): 3760. http://dx.doi.org/10.1182/blood.v114.22.3760.3760.
Texto completoHarahsheh, Ashraf, Sanjeev Aggarwal, Michael D. Pettersen y Thomas L’Ecuyer. "Diastolic function in anthracycline-treated children". Cardiology in the Young 25, n.º 6 (23 de septiembre de 2014): 1130–35. http://dx.doi.org/10.1017/s1047951114001760.
Texto completoPiccart-Gebhart, Martine J., Tomasz Burzykowski, Marc Buyse, George Sledge, James Carmichael, Hans-Joachim Lück, John R. Mackey et al. "Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer". Journal of Clinical Oncology 26, n.º 12 (20 de abril de 2008): 1980–86. http://dx.doi.org/10.1200/jco.2007.10.8399.
Texto completoMegias-Vericat, Juan Eduardo, David Martínez-Cuadrón, Joaquin Martínez López, Juan Miguel Bergua, Mar Tormo, Josefina Serrano, Ataulfo González et al. "DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA". Mediterranean Journal of Hematology and Infectious Diseases 11, n.º 1 (26 de febrero de 2019): e2019016. http://dx.doi.org/10.4084/mjhid.2019.016.
Texto completoCreutzig, Ursula, Sylke Diekamp, Martin Zimmermann y Dirk Reinhardt. "Long Term Data on Anthracycline Cardiotoxicity in 547 Children with AML." Blood 108, n.º 11 (1 de noviembre de 2006): 2014. http://dx.doi.org/10.1182/blood.v108.11.2014.2014.
Texto completoCheong, Alison, Sean McGrath y Suzanne Cutts. "Anthracyclines". WikiJournal of Medicine 5, n.º 1 (6 de diciembre de 2018): 1. http://dx.doi.org/10.15347/wjm/2018.001.
Texto completo&NA;. "Anthracyclines". Reactions Weekly &NA;, n.º 433 (enero de 1993): 6. http://dx.doi.org/10.2165/00128415-199304330-00012.
Texto completo&NA;. "Anthracyclines". Reactions Weekly &NA;, n.º 371 (octubre de 1991): 4–5. http://dx.doi.org/10.2165/00128415-199103710-00011.
Texto completo&NA;. "Anthracyclines". Reactions Weekly &NA;, n.º 1293 (marzo de 2010): 9–10. http://dx.doi.org/10.2165/00128415-201012930-00021.
Texto completoDesmedt, Christine, Angelo Di Leo, Evandro de Azambuja, Denis Larsimont, Benjamin Haibe-Kains, Jean Selleslags, Suzette Delaloge et al. "Multifactorial Approach to Predicting Resistance to Anthracyclines". Journal of Clinical Oncology 29, n.º 12 (20 de abril de 2011): 1578–86. http://dx.doi.org/10.1200/jco.2010.31.2231.
Texto completoCheah, Irwin K., Richard M. Y. Tang, Xiaoyuan Wang, Karishma Sachaphibulkij, Suet Yen Chong, Lina H. K. Lim, Jiong-Wei Wang y Barry Halliwell. "Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine". Antioxidants 12, n.º 2 (30 de enero de 2023): 320. http://dx.doi.org/10.3390/antiox12020320.
Texto completoAttina’, Giorgio, Silvia Triarico, Alberto Romano, Palma Maurizi, Stefano Mastrangelo y Antonio Ruggiero. "Serum Biomarkers for the Detection of Cardiac Dysfunction in Childhood Cancers Receiving Anthracycline-Based Treatment". Biomedical and Pharmacology Journal 15, n.º 3 (29 de septiembre de 2022): 1311–21. http://dx.doi.org/10.13005/bpj/2468.
Texto completoPaukovcekova, Silvia, Maria Krchniakova, Petr Chlapek, Jakub Neradil, Jan Skoda y Renata Veselska. "Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors". International Journal of Molecular Sciences 23, n.º 15 (1 de agosto de 2022): 8549. http://dx.doi.org/10.3390/ijms23158549.
Texto completoFranco, Vivian I., Jacqueline M. Henkel, Tracie L. Miller y Steven E. Lipshultz. "Cardiovascular Effects in Childhood Cancer Survivors Treated with Anthracyclines". Cardiology Research and Practice 2011 (2011): 1–13. http://dx.doi.org/10.4061/2011/134679.
Texto completoPuzzovivo, Agata, Agnese Maria Fioretti, Carla Minoia, Roberta Villoni, Santa Carbonara, Giusi Graziano, Fabio Pavone, Attilio Guarini y Stefano Oliva. "Echocardiography Monitoring during Anthracycline Administration in Hodgkin and Non-Hodgkin’s Lymphoma: The Tei Index Evaluation". Journal of Personalized Medicine 12, n.º 2 (16 de febrero de 2022): 290. http://dx.doi.org/10.3390/jpm12020290.
Texto completoAngelotti, Austin, Deena Snoke, Rachel Cole, Genevieve Sparagna y Martha Belury. "Characterizing Cardiolipin Species in the Hearts After Anthracycline Administration". Current Developments in Nutrition 5, Supplement_2 (junio de 2021): 934. http://dx.doi.org/10.1093/cdn/nzab050_001.
Texto completoTagawa, Michihito, Genya Shimbo, Akiko Uemura y Kotaro Matsumoto. "Cardiomyopathy in a dog with multicentric lymphoma following treatment with several anthracyclines". Open Veterinary Journal 11, n.º 1 (19 de marzo de 2021): 6–10. http://dx.doi.org/10.4314/ovj.v11i1.2.
Texto completoGschwantler-Kaulich, D., A. Fink-Retter, T. Bachrich, M. Ledesma, E. Ruecklinger, E. Kubista y C. F. Singer. "Efficacy of primary systemic chemotherapy regimen containing anthracyclines with/without taxanes in comparison to CMF in women with early breast cancer". Journal of Clinical Oncology 25, n.º 18_suppl (20 de junio de 2007): 11098. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.11098.
Texto completoDadson, Keith, Oscar Calvillo-Argüelles, Paaladinesh Thavendiranathan y Filio Billia. "Anthracycline-induced cardiomyopathy: cellular and molecular mechanisms". Clinical Science 134, n.º 13 (julio de 2020): 1859–85. http://dx.doi.org/10.1042/cs20190653.
Texto completoChong, Wei, Huikun Zhang, Zhifang Guo, Limin Yang, Ying Shao, Xiaoli Liu, Yawen Zhao et al. "Aquaporin 1 promotes sensitivity of anthracycline chemotherapy in breast cancer by inhibiting β-catenin degradation to enhance TopoIIα activity". Cell Death & Differentiation 28, n.º 1 (19 de agosto de 2020): 382–400. http://dx.doi.org/10.1038/s41418-020-00607-9.
Texto completo